|
|
||||||||
The Journal of Medical Microbiology, Vol 25, Issue 3 227-233, Copyright © 1988 by Society for General Microbiology
JOURNAL ARTICLE |
Y. J. Yang, D. M. Livermore and R. J. Williams
Department of Medical Microbiology, London Hospital Medical College.
The activities of beta-lactam antibiotics were compared against Enterobacter cloacae clinical isolates and mutants which had inducible, stably-derepressed, and basal expression of a pI 8.4 subtype of the Ia chromosomal beta-lactamase. These activities were correlated with the results of studies of the beta-lactamase-lability and beta-lactamase-inducer-power of the antibiotics. Cefoxitin and ampicillin were labile, and induced beta-lactamase production strongly at concentrations below their MIC values. Consequently, beta-lactamase-inducible and beta-lactamase-stably-derepressed organisms were highly resistant (MIC greater than 256 mg/L) to these antibiotics, whereas enzyme-basal strains and mutants were much more susceptible (MIC 1-16 mg/L). Imipenem also induced beta-lactamase production strongly at concentrations below its MIC, but was more stable than ampicillin and cefoxitin. It was active against enzyme-inducible and stably-derepressed organisms at 0.25-0.5 mg/L and against beta-lactamase-basal organisms at 0.06-0.25 mg/L. Thus the beta-lactamase afforded only very low-level protection against imipenem; this appeared to be by a non-hydrolytic mechanism, with the enzyme binding to the antibiotic in a relatively stable complex. This complex, which probably was an intermediate in a hydrolytic pathway, was isolated by gelfiltration chromatography and shown to have a breakdown half-life of 47 +/- 2 min. Cefotaxime, ceftriaxone and mezlocillin were labile to the pI 8.4 beta-lactamase but induced beta-lactamase production weakly at concentrations below their MIC values. Consequently, beta-lactamase-inducible and beta-lactamase-basal organisms remained equally susceptible (MIC 0.06-4 mg/L), but stably-derepressed organisms were considerably more resistant (MIC greater than 64 mg/L) to these antibiotics.
This article has been cited by other articles:
![]() |
S. Mushtaq, M. Warner, Y. Ge, K. Kaniga, and D. M. Livermore In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes J. Antimicrob. Chemother., August 1, 2007; 60(2): 300 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Pham, S. M. Bell, L. Martin, and E. Carniel The {beta}-lactamases and {beta}-lactam antibiotic susceptibility of Yersinia enterocolitica J. Antimicrob. Chemother., December 1, 2000; 46(6): 951 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Girlich, T. Naas, S. Bellais, L. Poirel, A. Karim, and P. Nordmann Biochemical-Genetic Characterization and Regulation of Expression of an ACC-1-Like Chromosome-Borne Cephalosporinase from Hafnia alvei Antimicrob. Agents Chemother., June 1, 2000; 44(6): 1470 - 1478. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |